Find your path to Axel
184 people in our graph share verified history with Axel — schools, employers, funds. One of them is your warm intro.
About
Axel Bolte is Chief Executive Officer of Altimis Bio LLC. He co-founded Inozyme Pharma (INZY), a Nasdaq-listed rare disease company focused on treatments for metabolic diseases, where he served as director and previously as President and CEO. His background includes board roles in private and public companies and a prior career in private equity investing in healthcare companies internationally.
Founder at Inozyme Pharma
Intro paths
In turn, Axel can intro founders to Inozyme Pharma's investors below.
Experience
- Altimis Bio LLCChief Executive Officercurrent2026 — presentBoston, Massachusetts, United States
- Opna BioDirectorcurrent2024 — presentSan Francisco, California, United States
- Burka Coffee Estates Ltd.Directorcurrent2003 — presentTanzania
- Mondul Coffee Estates Ltd.Directorcurrent2003 — presentMonduli, Arusha, Tanzania
- Inozyme PharmaCo-Founder2023 — 2025Boston, Massachusetts, United States
- Inozyme PharmaChief Executive Officer2017 — 2023Greater Boston
- Turos Capital AGCo-Founder2018 — 2023Zurich, Switzerland
- IVERIC bioDirector2019 — 2023New York City Metropolitan Area
- Tripex Pharmaceuticals LLCManaging Member2015 — 2021San Diego County, California, United States
- HBM Partners AGVenture Partner2017 — 2019Zug
- HBM Partners AGInvestment Advisor2013 — 2017Zurich, Switzerland
- Allena Pharmaceuticals, Inc.Board Member2014 — 2019Newton, MA
- Nabriva Therapeutics plcDirector2006 — 2019Vienna
- Ophthotech CorpDirector2007 — 2019New York City Metropolitan Area
- AnaptysBioBoard Observer2015 — 2017San Diego County, California, United States
- Kolltan Pharmaceuticals, Inc.Vice Chairman of the Board2008 — 2016New Haven, CT
- PTC Therapeutics (PTCT)Director2003 — 2014New York City Metropolitan Area
- The Trout GroupUS Investment Advisor to HBM Partners2008 — 2013New York City Metropolitan Area
- Enanta PharmaceuticalsBoard Observer2005 — 2013Greater Boston
- Mpex PharmaceuticalsDirector2006 — 2011San Diego County, California, United States
- HBM Partners AGInvestment Advisor2003 — 2008Zurich, Switzerland
- Newron Pharmaceuticals SpaDirector2005 — 2008Milan, Lombardy, Italy
Skills & more
+12 more
Medicinal ChemistryExecutive PayVenture CapitalInfectious DiseasesLifesciencesPharmacologyMergers & AcquisitionsClinical DevelopmentTechnology TransferIPOBiopharmaceuticalsClinical TrialsLanguages English · French · German · Spanish
From Axel's professional profile.
Frequently asked questions
- Who is Axel Bolte?
- Axel Bolte is Chief Executive Officer of Altimis Bio LLC. He co-founded Inozyme Pharma (INZY), a Nasdaq-listed rare disease company focused on treatments for metabolic diseases, where he served as director and previously as President and CEO. His background includes board roles in private and public companies and a prior career in private equity investing in healthcare companies internationally.
- Where does Axel Bolte work?
- Axel Bolte is Founder of Inozyme Pharma.
- What companies did Axel Bolte found?
- Axel Bolte founded Inozyme Pharma.
- Where did Axel Bolte go to school?
- Axel Bolte studied at ETH Zürich (Dipl. Natw. ETH, Biochemistry); University of St.Gallen (lic.oec.HSG, Business Administration and Management); University of Cambridge (Organic Chemistry).
Founder mafias
University of Cambridge mafia589
Also came through, then founded or led a company.
+ 582 more
ETH Zürich mafia196
Also came through, then founded or led a company.
+ 189 more
AnaptysBio mafia2
Also came through, then founded or led a company.
Enanta Pharmaceuticals mafia2
Also came through, then founded or led a company.
HBM Partners mafia2
Also came through, then founded or led a company.
Same school
Also attended ETH Zürich362
+ 356 more
Also attended University of St.Gallen399
+ 393 more
Also attended University of Cambridge1,491
+ 1,485 more














































